New treatments for malignant melanoma.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D012107:Research Design
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D003606:Dacarbazine